Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder
Researchers have published preclinical data showing that a liver-directed gene therapy can effectively treat methylmalonic acidemia (MMA) in mice. The study demonstrates sustained improvements in disease markers, offering hope for a future treatment for this rare metabolic disorder.
Why it matters
MMA is a severe, life-shortening condition with no currently approved disease-targeted drugs, making this a significant potential breakthrough in genetic medicine.
edited by Gaby Clark , reviewed by Andrew Zinin
The article reports on scientific findings published in a peer-reviewed journal with a focus on medical data.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in